CN101228271A - 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 - Google Patents
一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 Download PDFInfo
- Publication number
- CN101228271A CN101228271A CNA2006800268150A CN200680026815A CN101228271A CN 101228271 A CN101228271 A CN 101228271A CN A2006800268150 A CNA2006800268150 A CN A2006800268150A CN 200680026815 A CN200680026815 A CN 200680026815A CN 101228271 A CN101228271 A CN 101228271A
- Authority
- CN
- China
- Prior art keywords
- staphylococcus lysozyme
- intestinal bacteria
- expressed
- gly
- escherichia coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 15
- 108090000988 Lysostaphin Proteins 0.000 title abstract description 13
- 230000014509 gene expression Effects 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- 230000028327 secretion Effects 0.000 claims abstract description 20
- 108010076504 Protein Sorting Signals Proteins 0.000 claims abstract description 17
- 239000006228 supernatant Substances 0.000 claims abstract description 10
- 238000000855 fermentation Methods 0.000 claims abstract description 4
- 230000004151 fermentation Effects 0.000 claims abstract description 4
- 108010014251 Muramidase Proteins 0.000 claims description 72
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 72
- 241000191940 Staphylococcus Species 0.000 claims description 72
- 102000016943 Muramidase Human genes 0.000 claims description 66
- 229960000274 lysozyme Drugs 0.000 claims description 66
- 235000010335 lysozyme Nutrition 0.000 claims description 66
- 239000004325 lysozyme Substances 0.000 claims description 66
- 241000894006 Bacteria Species 0.000 claims description 30
- 230000000968 intestinal effect Effects 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 12
- 108010079246 OMPA outer membrane proteins Proteins 0.000 claims description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
- 101100136076 Aspergillus oryzae (strain ATCC 42149 / RIB 40) pel1 gene Proteins 0.000 claims description 3
- 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 claims description 3
- 101150040383 pel2 gene Proteins 0.000 claims description 3
- 101150050446 pelB gene Proteins 0.000 claims description 3
- 101150009573 phoA gene Proteins 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 102000004169 proteins and genes Human genes 0.000 abstract description 12
- 239000000047 product Substances 0.000 abstract description 8
- 210000003000 inclusion body Anatomy 0.000 abstract description 7
- 230000008569 process Effects 0.000 abstract description 6
- 238000004153 renaturation Methods 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 4
- 238000010367 cloning Methods 0.000 abstract 1
- 238000011109 contamination Methods 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 44
- 230000009182 swimming Effects 0.000 description 15
- 239000000523 sample Substances 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000012530 fluid Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000012925 reference material Substances 0.000 description 7
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 6
- 238000013016 damping Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 230000008521 reorganization Effects 0.000 description 6
- 241000186660 Lactobacillus Species 0.000 description 5
- 238000004737 colorimetric analysis Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 210000002421 cell wall Anatomy 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 239000002547 new drug Substances 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- 241000191978 Staphylococcus simulans Species 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 2
- 108010013639 Peptidoglycan Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 239000003398 denaturant Substances 0.000 description 2
- 238000007905 drug manufacturing Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102220023256 rs387907547 Human genes 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241001314279 Zoopagales Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 102220369446 c.1274G>A Human genes 0.000 description 1
- 102220369445 c.668T>C Human genes 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000007247 enzymatic mechanism Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000028023 exocytosis Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006800268150A CN101228271B (zh) | 2005-07-22 | 2006-07-11 | 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100280380A CN100475965C (zh) | 2005-07-22 | 2005-07-22 | 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 |
CN200510028038.0 | 2005-07-22 | ||
PCT/CN2006/001640 WO2007009351A1 (en) | 2005-07-22 | 2006-07-11 | A method of secretion expression of lysostaphin in escherichia coli at high level |
CN2006800268150A CN101228271B (zh) | 2005-07-22 | 2006-07-11 | 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101228271A true CN101228271A (zh) | 2008-07-23 |
CN101228271B CN101228271B (zh) | 2011-10-26 |
Family
ID=37656277
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100280380A Active CN100475965C (zh) | 2005-07-22 | 2005-07-22 | 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 |
CN2006800268150A Active CN101228271B (zh) | 2005-07-22 | 2006-07-11 | 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100280380A Active CN100475965C (zh) | 2005-07-22 | 2005-07-22 | 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US8241901B2 (zh) |
EP (1) | EP1918369B1 (zh) |
JP (1) | JP5242388B2 (zh) |
KR (1) | KR101098353B1 (zh) |
CN (2) | CN100475965C (zh) |
WO (1) | WO2007009351A1 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103509777A (zh) * | 2013-09-30 | 2014-01-15 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种特异定量检测葡萄球菌的方法 |
CN113005134A (zh) * | 2021-03-12 | 2021-06-22 | 厦门宝太生物科技有限公司 | 一种促进胶质纤维酸性蛋白在大肠杆菌中大量表达的方法 |
CN113717964A (zh) * | 2013-08-06 | 2021-11-30 | 达特茅斯学院理事会 | 非糖基化溶葡球菌素变体蛋白 |
CN114540385A (zh) * | 2022-03-21 | 2022-05-27 | 齐鲁工业大学 | 一种利用大肠杆菌产溶葡萄球菌酶的方法 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101302504B (zh) * | 2007-05-11 | 2011-12-21 | 上海高科联合生物技术研发有限公司 | 一种抗体亲和层析纯化溶葡萄球菌酶的方法 |
KR20140004219A (ko) * | 2011-04-08 | 2014-01-10 | 앤섬 바이오사이언시즈 프라이빗 리미티드 | 대장균에서 이형 단백질 생산을 위한 새로운 발현 및 분비 벡터 시스템 |
WO2014078373A1 (en) * | 2012-11-13 | 2014-05-22 | Iogenetics, Llc | Antimicrobial compositions |
US9814766B2 (en) | 2013-12-28 | 2017-11-14 | Longhorn Vaccines And Diagnostics, Llc | Multimodal antimicrobial therapy |
US10435694B2 (en) | 2014-03-14 | 2019-10-08 | Genentech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
AR103852A1 (es) | 2015-03-06 | 2017-06-07 | Genentech Inc | DsbA Y DsbC ULTRAPURIFICADOS Y SUS MÉTODOS DE PREPARACIÓN Y USO |
MX2018014047A (es) | 2016-05-17 | 2019-06-20 | Genentech Inc | Firmas de genes estromales para el diagnóstico y uso en inmunoterapia. |
AR108800A1 (es) | 2016-06-17 | 2018-09-26 | Genentech Inc | Purificación de anticuerpos multiespecíficos |
CN107916244A (zh) * | 2017-06-20 | 2018-04-17 | 江西嘉博生物工程有限公司 | 一种表达溶葡球菌素基因的重组乳酸乳球菌的构建方法及应用 |
CN111560048B (zh) * | 2020-06-03 | 2021-08-13 | 成都正能生物技术有限责任公司 | 用于提取金黄色葡萄球菌总蛋白的方法及试剂盒 |
CN112062820B (zh) * | 2020-08-24 | 2023-05-26 | 黑龙江八一农垦大学 | 大肠杆菌重组外膜蛋白a包涵体蛋白的复性纯化方法 |
CN115873834B (zh) * | 2022-08-26 | 2024-06-04 | 山东大学 | 一种溶葡萄球菌酶变体及其制备方法和应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3278378A (en) | 1962-04-19 | 1966-10-11 | Schindler Charles Alvin | Staphylococcus-derived antibiotic |
US4931390A (en) | 1986-04-16 | 1990-06-05 | Public Health Research Institute Of The City Of New York, Inc. | Expression of the cloned lysostaphin gene |
JP3226289B2 (ja) * | 1991-02-13 | 2001-11-05 | 株式会社ジャパンエナジー | 分泌ベクター、該ベクターで形質転換した微生物及び該微生物から産生される産物の製造法 |
DE4425645A1 (de) | 1994-07-20 | 1996-02-22 | Mueller Karl & Co Kg | Deletiertes Lysostaphingen von Staphylococcus simulans |
US6132954A (en) * | 1996-08-20 | 2000-10-17 | Baylor College Of Medicine | Methods of screening for agents that delay a cell cycle and compositions comprising era and an analogue of wild-type era |
US6083715A (en) * | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
US6875903B2 (en) * | 1998-06-22 | 2005-04-05 | University Of Vermont | Treatment of Staphylococcus infections |
CN1267551C (zh) * | 1999-10-19 | 2006-08-02 | 印度生物技术国际有限公司 | 重组成熟溶葡萄球菌素的表达 |
PT2270030E (pt) * | 2000-02-28 | 2012-07-24 | Novartis Vaccines & Diagnostic | Expressão heteróloga de proteínas de neisseria |
CN1911965B (zh) * | 2001-01-17 | 2013-05-29 | 新兴产品开发西雅图有限公司 | 结合域-免疫球蛋白融合蛋白 |
MXPA04001566A (es) * | 2001-08-27 | 2004-05-17 | Genentech Inc | Un sistema para expresion y ensamblado de anticuerpos. |
JP4348194B2 (ja) * | 2001-12-21 | 2009-10-21 | バイオシネクサス インコーポレーテッド | ブドウ球菌溶解活性が増強された切断型リゾスタフィン分子 |
WO2003074705A1 (fr) * | 2002-03-01 | 2003-09-12 | Japan Envirochemicals, Ltd. | Proteines capables de se fixer sur des hormones environnementales et procede permettant de les produire |
-
2005
- 2005-07-22 CN CNB2005100280380A patent/CN100475965C/zh active Active
-
2006
- 2006-07-11 CN CN2006800268150A patent/CN101228271B/zh active Active
- 2006-07-11 US US11/995,735 patent/US8241901B2/en active Active
- 2006-07-11 KR KR1020087001751A patent/KR101098353B1/ko active IP Right Grant
- 2006-07-11 WO PCT/CN2006/001640 patent/WO2007009351A1/zh active Application Filing
- 2006-07-11 EP EP20060761397 patent/EP1918369B1/en active Active
- 2006-07-11 JP JP2008521775A patent/JP5242388B2/ja active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113717964A (zh) * | 2013-08-06 | 2021-11-30 | 达特茅斯学院理事会 | 非糖基化溶葡球菌素变体蛋白 |
CN103509777A (zh) * | 2013-09-30 | 2014-01-15 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种特异定量检测葡萄球菌的方法 |
CN103509777B (zh) * | 2013-09-30 | 2016-03-30 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种特异定量检测葡萄球菌的方法 |
CN113005134A (zh) * | 2021-03-12 | 2021-06-22 | 厦门宝太生物科技有限公司 | 一种促进胶质纤维酸性蛋白在大肠杆菌中大量表达的方法 |
CN113005134B (zh) * | 2021-03-12 | 2022-06-03 | 厦门宝太生物科技股份有限公司 | 一种促进胶质纤维酸性蛋白在大肠杆菌中大量表达的方法 |
CN114540385A (zh) * | 2022-03-21 | 2022-05-27 | 齐鲁工业大学 | 一种利用大肠杆菌产溶葡萄球菌酶的方法 |
Also Published As
Publication number | Publication date |
---|---|
JP2009502125A (ja) | 2009-01-29 |
US8241901B2 (en) | 2012-08-14 |
KR101098353B1 (ko) | 2011-12-26 |
EP1918369B1 (en) | 2015-05-20 |
EP1918369A1 (en) | 2008-05-07 |
KR20080018960A (ko) | 2008-02-28 |
WO2007009351A1 (en) | 2007-01-25 |
CN1900290A (zh) | 2007-01-24 |
JP5242388B2 (ja) | 2013-07-24 |
CN100475965C (zh) | 2009-04-08 |
CN101228271B (zh) | 2011-10-26 |
US20090186380A1 (en) | 2009-07-23 |
EP1918369A4 (en) | 2009-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100475965C (zh) | 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 | |
CN101432296B (zh) | 聚乙二醇化的突变的肉毒梭菌毒素 | |
Honoré et al. | Regulation of enterobacterial cephalosporinase production: the role of a membrane‐bound sensory transducer | |
Egelseer et al. | The S-layer proteins of two Bacillus stearothermophilus wild-type strains are bound via their N-terminal region to a secondary cell wall polymer of identical chemical composition | |
CN113383015B (zh) | 重组蛋白变体 | |
CN110128521A (zh) | 用于生产重组融合蛋白的辅助蛋白、编码基因、重组融合蛋白、重组表达载体及制备方法 | |
JP2009502125A5 (zh) | ||
CN108642030A (zh) | 新重组因子c、其制造方法、及内毒素的测定法 | |
DK2185699T3 (en) | NEW PROTEINS FOR USE IN STAPHYLOCOCCUS INFECTIONS IN HUMAN AND ANIMALS | |
Herlihey et al. | Modulation of the lytic activity of the dedicated autolysin for flagellum formation SltF by flagellar rod proteins FlgB and FlgF | |
CN109486800A (zh) | 一种新型赖氨酰肽链内切酶及其制备方法 | |
Lee et al. | Involvement of NH2-terminal pro-sequence in the production of active aqualysin I (a thermophilic serine protease) in Escherichia coli | |
Hilbert et al. | A Periplasmicd-Alanyl-d-Alanine Dipeptidase in the Gram-Negative Bacterium Salmonella enterica | |
Aghaeepoor et al. | Optimization and high level production of recombinant synthetic Streptokinase in E. coli using Response Surface Methodology | |
Piatek et al. | Molecular aspects of biogenesis of Escherichia coli Dr Fimbriae: characterization of DraB-DraE complexes | |
Wang et al. | Bioimmobilization of keratinase using Bacillus subtilis and Escherichia coli systems | |
Maqbool et al. | MpaA is a murein-tripeptide-specific zinc carboxypeptidase that functions as part of a catabolic pathway for peptidoglycan-derived peptides in γ-proteobacteria | |
CN109439643A (zh) | 一种新型赖氨酸特异性内切酶及其制备方法 | |
US20240076705A1 (en) | Lambda-carrageenase mutant ouc-cgla-dpqq and application thereof | |
CN101497863B (zh) | 一种制备N-末端乙酰化的胸腺素α1的方法及其专用工程菌 | |
Marczak et al. | PssP2 is a polysaccharide co-polymerase involved in exopolysaccharide chain-length determination in Rhizobium leguminosarum | |
CN101608179B (zh) | 融合肝素酶及其编码基因 | |
CN101979505A (zh) | N-末端乙酰化蛋白或多肽的制备方法及其专用工程菌 | |
CN101962654B (zh) | 胸苷酸合成酶在大肠杆菌中的高效表达 | |
CN102257139A (zh) | 制备能够形成包含体的蛋白的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170217 Address after: Yushan town of Kunshan city Jiangsu province 215316 ring Hing Road No. 2199 room 2 Patentee after: Jiangsu Bokun Biological Technology Co.,Ltd. Address before: 201206 Shanghai, Pudong New Area, Hong Kong Road, No. 501, block B, floor 3 Patentee before: Shanghai Hi-Tech United Bio-Technological Research & Development Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171019 Address after: 222000, Lianyungang economic and Technological Development Zone, Jiangsu Province Export Processing Zone Building 402 room Patentee after: Jiangsu Bolian Biological Engineering Co.,Ltd. Address before: Yushan town of Kunshan city Jiangsu province 215316 ring Hing Road No. 2199 room 2 Patentee before: Jiangsu Bokun Biological Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180810 Address after: 201206, 3 / F, block B, 501 Jin Gang Road, Pudong New Area, Shanghai. Patentee after: Shanghai Hi-Tech United Bio-Technological Research & Development Co.,Ltd. Address before: 222000 room 402, comprehensive building, export processing zone, Lianyungang economic and Technological Development Zone, Jiangsu Patentee before: Jiangsu Bolian Biological Engineering Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221223 Address after: 201206 floors 4-5, building B, No. 501, Jingang Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Patentee after: Shanghai Hi-tech Bioengineering Ltd. Address before: 201206, No. 3, building B, block 501, Jingang Road, Shanghai, Pudong New Area Patentee before: Shanghai Hi-Tech United Bio-Technological Research & Development Co.,Ltd. |